Metastatic Renal Cell Carcinoma ( mRCC)Fase 2NCT06601296
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
IMSA101
43 estudios reclutando ahora mismo, los actualizados más recientemente primero.
Abrir la página de fase 2 · una lista solo de esos estudios
Triangle is made by Triangle Health, Inc.
Riñón y vejiga43 estudios
Metastatic Renal Cell Carcinoma ( mRCC)Fase 2NCT06601296
IMSA101
Hereditary Leiomyomatosis and Renal Cell CarcinomaFase 2NCT04981509
Atezolizumab, Bevacizumab, Biopsy Procedure, Biospecimen Collection
Bladder AdenocarcinomaFase 2NCT03866382Artículos
Biospecimen Collection, Bone Scan, Cabozantinib S-malate, Computed Tomography
Low-grade NMIBCFase 2NCT06995677
TYRA-300 60mg, TYRA-300 50mg, TYRA-300 Dose 70 mg
Localized Clear Cell Renal Cell CarcinomaFase 2NCT07226544
Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test
RCCFase 2NCT05931393
Cabozantinib 80 MG
Carcinoma de células renales metastásicoFase 2NCT05327686
Avelumab, Axitinib, Biospecimen Collection, Bone Scan
Muscle-invasive Bladder CancerFase 2NCT07475806
Enfortumab Vedotin, Pembrolizumab
Clear Cell Renal Cell CarcinomaFase 2NCT07516366
Balstilimab, Biospecimen Collection, Botensilimab, Computed Tomography
Clear Cell Renal Cell CarcinomaFase 2NCT07037004
Biospecimen Collection, Clostridium butyricum CBM588 Strain, Computed Tomography, Pembrolizumab
Non-Muscle Invasive Bladder Urothelial CarcinomaFase 2NCT06770582
Biospecimen Collection, Cisplatin, Computed Tomography, Fluorouracil
Small Cell Carcinoma of the BladderFase 2NCT06228066Artículos
Lurbinectedin, Avelumab
Small Cell Carcinoma of the BladderFase 2NCT06161532Artículos
Sacituzumab govitecan, Atezolizumab
Carcinoma de células renales de células claras avanzado o metastásicoFase 1NCT07564232
LNK001 en el carcinoma de células renales de células claras avanzado o metastásico
Locally Advanced Urothelial CarcinomaFase 2NCT07048457
Radical cystectomy
Renal Cell CarcinomaFase 2NCT06053658
Tivozanib, Nivolumab
Non-muscle Invasive Bladder CancerFase 2NCT06503614
Durvalumab, Monalizumab
Bladder Urothelial CarcinomaFase 2NCT06263153
Biospecimen Collection, Computed Tomography, Durvalumab, Futibatinib
Phase IIFase 2NCT07438626
Sacituzumab tirumotecan
Renal Cell CarcinomaFase 2NCT05319015
Neoadjuvant Lenvatinib, Neoadjuvant Pembrolizumab, Radical nephrectomy, IVC thrombectomy, retroperitoneal lymph node dissection, Adjuvant Pembrolizumab
Urothelial Carcinoma BladderFase 2NCT06184516
Reproductive organ sparing radical cystectomy, Radical cystectomy
Advanced Renal Cell Carcinoma (aRCC)Fase 2NCT07188896
Fianlimab, Ipilimumab, Nivolumab, Cemiplimab
Locally Advanced Renal Cell CarcinomaFase 2NCT06794229
Zanzalintinib, Nivolumab
High-Risk Non-Muscle-Invasive Bladder CancerFase 2NCT06567743
Cretostimogene Grenadenorepvec